hughes-stovin syndrome (HSS) is a rare potentially fatal vasculitis supposedly belonging to the spectrum of behçet disease without ocular involvement. HSS tends to play by a temporal pattern, starting with thrombosis and followed by formation of pulmonary aneurysms. wince its mortality can reach 25% of cases, early recognition and appropriate therapy represent the major clinical challenges. we describe a rare case of HSS successfully treated via multidisciplinary management by an endovascular approach and immunosuppressive therapy.
ASCOLI MARCHETTI, A., Belvivere, L., Argirò, R., Kroegler, B., Oddi, F.m., Pennetta, F., et al. (2024). A rare but fatal behçet variant: the hughes–stovin syndrome—successful case report and new evidence from literature review. AORTA [10.1055/s-0043-1777994].
A rare but fatal behçet variant: the hughes–stovin syndrome—successful case report and new evidence from literature review
Andrea Ascoli Marchetti
;Lorella Belvivere;Fabio M. Oddi;Federico Pennetta;Alice de Giorgi;Stefano Fazzini;Daniele Morosetti;Paola Triggianese;Arianna D'Antonio;Ilaria Coccia;Manfredi Tesauro;Federica Sangiuolo;Arnaldo Ippoliti
2024-01-01
Abstract
hughes-stovin syndrome (HSS) is a rare potentially fatal vasculitis supposedly belonging to the spectrum of behçet disease without ocular involvement. HSS tends to play by a temporal pattern, starting with thrombosis and followed by formation of pulmonary aneurysms. wince its mortality can reach 25% of cases, early recognition and appropriate therapy represent the major clinical challenges. we describe a rare case of HSS successfully treated via multidisciplinary management by an endovascular approach and immunosuppressive therapy.File | Dimensione | Formato | |
---|---|---|---|
aorta.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
2.24 MB
Formato
Adobe PDF
|
2.24 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.